Neuroradiology: Page 207

CTA assesses traumatic neurovascular injury
By Eric Barnes
In the setting of neurovascular trauma, CT's excellent image quality isn't enough to predict complications and manage patients optimally, particularly those who present with few or no neurological symptoms. New markers and tests may eventually improve the ability to predict complications. For now, careful attention to clinical and imaging data is key.
October 15, 2006
fMRI helps explain social dysfunction with autism
By Edward Susman
CHICAGO - Disruption of the mirror neuron system as seen on functional MRI (fMRI) may explain the social dysfunction associated with autism, according to a presentation this week at the American Neurological Association (ANA) meeting.
October 9, 2006
Barnes-Jewish to install IMRIS intraoperative MRI
By AuntMinnie.com staff writers
Barnes-Jewish Hospital in St. Louis, MO, will install IMRIS' iSpace surgical imaging suite, which will allow the facility's neurosurgeons to perform MRI scans while surgery is in progress.
October 4, 2006
PET helps uncover dopamine's influence on alcoholism
By Wayne Forrest
Positron emission tomography (PET) is helping researchers determine if a connection exists between dopamine levels in the brain and the risk of alcoholism within a family, or the threat of relapse for a detoxified alcoholic.
October 4, 2006
BrainLab introduces Kolibri 2.0
By AuntMinnie.com staff writers
Image-guided therapy firm BrainLab USA of Westchester, IL, has released Kolibri 2.0, a portable image-guided surgery platform for ear, nose, and throat (ENT) applications.
October 1, 2006
MRI market to top $4 billion by 2010
By AuntMinnie.com staff writers
Increases in the use of interventional MRI in brain surgery will drive the worldwide MRI market to $4 billion in anticipated revenues by 2010, according to research firm Kalorama Information.
September 4, 2006
Better enhancement, fewer artifacts seen with certain -- but not all -- MR contrast agents
By Shalmali Pal
Two new studies evaluated three different MR contrast agents for brain and spinal imaging. In the first study, a multi-institutional group compared two gadolinium-based contrast agents for the enhancement of central nervous system (CNS) lesions. In the second, researchers tested a half-life gadolinium-based contrast agent in functional MRI (fMRI).
September 4, 2006
2006 08 31 16 18 42 706
McGovern Institute lands neuroscience award
By AuntMinnie.com staff writers
The McKnight Endowment Fund for Neuroscience has awarded its Technological Innovations in Neuroscience Award to a researcher at the Massachusetts Institute of Technology's McGovern Institute for Brain Research.
August 15, 2006
BrainLab adds Novalis sales
By AuntMinnie.com staff writers
Image-guided therapy firm BrainLab has signed contracts for its Novalis Shaped Beam surgery systems at three facilities in the U.S.
August 15, 2006
BrainLab releases iPlan RT
By AuntMinnie.com staff writers
Image-guided therapy firm BrainLab has released its complete iPlan RT treatment planning platform at the annual meeting of the American Association of Physicists in Medicine (AAPM) in Orlando.
July 31, 2006
Alzheimer's Association funds PET scan study
By AuntMinnie.com staff writers
The Alzheimer's Association has awarded a $2.1 million research grant to the Alzheimer's Disease Neuroimaging Initiative (ADNI). The funds will be used to expand the five-year study to include PET scans using Pittsburgh Compound B (PiB), according to the association.
July 23, 2006
Schering, Avid partner on Alzheimer's agents
By AuntMinnie.com staff writers
German contrast media firm Schering is partnering with molecular imaging developer Avid Radiopharmaceuticals to develop diagnostic imaging agents for Alzheimer’s disease.
July 16, 2006
Previous Page
Page 207 of 238
Next Page